Showing results (41-50 of 153) with videos related to
Sort By:
Pageof 16
Journal of Surgical Oncology|December 26, 2009
Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysisSuzanne C Schiffman, Charles E Woodall, David A Kooby, et al.The American Surgeon|September 28, 2011
Risk factors for pancreatic fistula after stapled gland transectionPreeti D Subhedar, Sameer H Patel, Peter J Kneuertz, et al.Journal of Surgical Oncology|August 27, 2019
A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative techniqueAdriana C Gamboa, Yuan Liu, Rachel M Lee, et al.Journal of the American College of Surgeons|May 27, 2008
Epidural analgesia in hepatic resectionAndrew Page, Bradley Rostad, Charles A Staley, et al.Annals of Surgical Oncology|September 25, 2014
Association between hospital finances, payer mix, and complications after hyperthermic intraperitoneal chemotherapy: deficiencies in the current healthcare reimbursement system and future implicationsMalcolm H Squires, Christopher A Staley, William Knechtle, et al.The Journal of Surgical Research|May 13, 2021
Elderly Patients Benefit From Enhanced Recovery Protocols After Colorectal SurgeryJessica Y Liu, Sebastian D Perez, Glen G Balch, et al.The American Surgeon|July 27, 2016
Is there an Optimal Surgical Approach to Neuroendocrine Tumors of the Ampulla? A Single Institution Experience Over 15 YearsGillian G Baptiste, Lauren M Postlewait, Cecilia G Ethun, et al.Journal of the American College of Surgeons|February 25, 2017
Decreasing Hospital Readmission in Ileostomy Patients: Results of Novel Pilot ProgramVirginia O Shaffer, Tari Owi, Mathu A Kumarusamy, et al.Journal of Surgical Oncology|June 29, 2022
Implications of leukocytosis following distal pancreatectomy splenectomy (DPS) and association with postoperative complicationsJessica Y Labib, Brendan P Lovasik, Neha Lad, et al.Cancer|January 5, 2013
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204Jerome C Landry, Yang Feng, Steven J Cohen, et al.Pageof 16